Samit Hirawat has been appointed as Strategic Medical Advisor at JEITO, reinforcing the firm’s focus on science-led investments and patient-centric innovation. In this role, he will contribute to shaping JEITO’s investment strategy while providing clinical and strategic guidance across its portfolio companies.

Samit brings exemplary global leadership experience in clinical development and therapeutic innovation, having held senior roles at Novartis and Bristol Myers Squibb. Throughout his career, he has been instrumental in advancing patient-focused drug development and driving innovation across multiple therapeutic areas.

With a strong track record in integrating science with strategic investment decisions, he is well-positioned to support JEITO’s mission of accelerating high-impact healthcare solutions. His appointment is expected to further strengthen the firm’s ability to identify, support, and scale breakthrough therapies for global patient populations.